Jazz Pharmaceuticals plc buy The Goldman Sachs Group, Inc.
Start price
03.03.23
/
50%
€137.36
Target price
03.03.24
€199.47
Performance (%)
-19.63%
End price
04.03.24
€110.40
Summary
This prediction ended on 04.03.24 with a price of €110.40. The price of Jazz Pharmaceuticals plc has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -19.63%. The_Goldman_Sachs_Gr has a follow-up prediction for Jazz Pharmaceuticals plc where he still thinks Jazz Pharmaceuticals plc is a Buy. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Jazz Pharmaceuticals plc | -0.390% | -0.390% | 20.240% |
| iShares Core DAX® | -1.212% | 1.925% | 17.589% |
| iShares Nasdaq 100 | -4.714% | -1.810% | 0.450% |
| iShares Nikkei 225® | -2.976% | -2.660% | 10.156% |
| iShares S&P 500 | -2.744% | -0.448% | 0.320% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Jazz Pharmaceuticals plc diskutieren
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $190.00 to $212.00. They now have a "buy" rating on the stock.
Ratings data for JAZZ provided by MarketBeat
In the thread Trading Jazz Pharmaceuticals plc
Die von The_Goldman_Sachs_Gr gewählte maximale Laufzeit wurde überschritten
Current prediction by The_Goldman_Sachs_Gr for Jazz Pharmaceuticals plc
Jazz Pharmaceuticals plc
Start price
Target price
Perf. (%)
€109.20
29.08.25
29.08.25
€158.67
29.08.26
29.08.26
29.62%
18.12.25
18.12.25
Stopped prediction by The_Goldman_Sachs_Gr for Jazz Pharmaceuticals plc
Jazz Pharmaceuticals plc
Start price
Target price
Perf. (%)
€98.06
05.06.24
05.06.24
€155.23
05.06.25
05.06.25
-1.35%
06.06.25
06.06.25